Source: Eur Respir J 2013; 42: 252-271
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Karin Weyer, Fuad Mirzayev, Giovanni Battista Migliori, Wayne Van Gemert, Lia D'Ambrosio, Matteo Zignol, Katherine Floyd, Rosella Centis, Daniela M. Cirillo, Enrico Tortoli, Chris Gilpin, Jean de Dieu Iragena, Dennis Falzon, Mario Raviglione. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271

Member's Comments

No comment yet.

Related content which might interest you: Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Source: Eur Respir J 2016; 48: 516-525 Year: 2016 Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis Source: Eur Respir J 2013; 42: 708-720 Year: 2013 Early tuberculosis treatment monitoring by Xpert® MTB/RIF Source: Eur Respir J 2012; 39: 1269-1271 Year: 2012 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries? Source: Eur Respir J 2015; 45: 549-554 Year: 2015 Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021 Year: 2021 Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis Source: Eur Respir J 2012; 40: 442-447 Year: 2012 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018 Year: 2019 Late Breaking Abstract - The tuberculosis diagnostic evaluation cascade of care at microscopy centers linked to Xpert MTB/RIF hubs in Uganda Source: International Congress 2017 – Update on TB: latest news Year: 2017 Clinical utility of the Xpert MTB/RIF test in induced sputum Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals Source: Eur Respir J 2016; 47: 575-587 Year: 2016 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India Source: Eur Respir J 2014; 44: 1090-1093 Year: 2014 Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis Source: Eur Respir J 2014; 44: 435-446 Year: 2014 Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014